distinct patterns of constitutive phosphodiesterase activity in mouse sinoatrial node and atrial myocardium不同的本构磷酸二酯酶活动模式在鼠标窦房结、心房心肌.pdfVIP

  • 1
  • 0
  • 约7.42万字
  • 约 12页
  • 2017-09-01 发布于上海
  • 举报

distinct patterns of constitutive phosphodiesterase activity in mouse sinoatrial node and atrial myocardium不同的本构磷酸二酯酶活动模式在鼠标窦房结、心房心肌.pdf

distinct patterns of constitutive phosphodiesterase activity in mouse sinoatrial node and atrial myocardium不同的本构磷酸二酯酶活动模式在鼠标窦房结、心房心肌

Distinct Patterns of Constitutive Phosphodiesterase Activity in Mouse Sinoatrial Node and Atrial Myocardium . . Rui Hua , Andrew Adamczyk , Courtney Robbins, Gibanananda Ray, Robert A. Rose* Department of Physiology and Biophysics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada Abstract Phosphodiesterases (PDEs) are critical regulators of cyclic nucleotides in the heart. In ventricular myocytes, the L-type Ca2+ current (ICa,L) is a major target of regulation by PDEs, particularly members of the PDE2, PDE3 and PDE4 families. Conversely, much less is known about the roles of PDE2, PDE3 and PDE4 in the regulation of action potential (AP) properties and ICa,L in the sinoatrial node (SAN) and the atrial myocardium, especially in mice. Thus, the purpose of our study was to measure the effects of global PDE inhibition with Isobutyl-1-methylxanthine (IBMX) and selective inhibitors of PDE2, PDE3 and PDE4 on AP properties in isolated mouse SAN and right atrial myocytes. We also measured the effects of these inhibitors on ICa,L in SAN and atrial myocytes in comparison to ventricular myocytes. Our data demonstrate that IBMX markedly increases spontaneous AP frequency in SAN myocytes and AP duration in atrial myocytes. Spontaneous AP firing in SAN myocytes was also increased by the PDE2 inhibitor erythro-9-[2-hydroxy-3-nonyl] adenine (EHNA), the PDE3 inhibitor milrinone (Mil) and the PDE4 inhibitor rolipram (Rol). In contrast, atrial AP duration was increased by EHNA and Rol, but not by Mil. IBMX also potently, and similarly, increased ICa,L in SAN, atrial and ventricular myocytes; however, important differences emerged in terms of which inhibitors could modulate ICa,L in each myocyte type. Consistent with our AP measurements, EHNA, Mil and Rol each increased ICa,L in SAN myocytes.

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档